Directly transferring healthy mitochondria or cytoplasmic components into target cells is particularly relevant for regenerative medicine.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.